Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-10

Clinical Trial Update: A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia [Phase 3]

View source ↗

Summary

Phase 3 pilot trial evaluating botulinum toxin for provoked vestibulodynia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Vestibulodynia | Phase 3 | Status: COMPLETED